Preventing Diabetes in Medicare Act of 2023

Bill 118 s 3233, also known as the Preventing Diabetes in Medicare Act of 2023, is a piece of legislation introduced in the US Congress with the aim of addressing the growing issue of diabetes among Medicare beneficiaries. The bill seeks to implement a comprehensive approach to preventing and managing diabetes in this population.

One of the key provisions of the bill is the establishment of a Diabetes Prevention Program within Medicare. This program would provide beneficiaries with access to evidence-based interventions aimed at preventing the onset of diabetes or delaying its progression. These interventions may include lifestyle modifications, such as diet and exercise, as well as education and support services.

Additionally, the bill calls for increased screening and testing for diabetes among Medicare beneficiaries. This would help identify individuals at risk for the disease and ensure they receive timely interventions to prevent its onset or manage it effectively. Furthermore, the Preventing Diabetes in Medicare Act of 2023 includes provisions to improve coordination of care for Medicare beneficiaries with diabetes. This may involve better communication between healthcare providers, as well as the use of technology to track and monitor patients' progress in managing their condition. Overall, the bill aims to address the growing prevalence of diabetes among Medicare beneficiaries by implementing a comprehensive approach to prevention and management. By providing access to evidence-based interventions, increasing screening and testing, and improving coordination of care, the legislation seeks to improve the health outcomes of individuals with diabetes and reduce the burden of the disease on the Medicare program.